U.S., July 22 -- ClinicalTrials.gov registry received information related to the study (NCT07716878) titled 'Isavuconazole Therapeutic Drug Monitoring in Transplant Recipients' on July 16.
Brief Summary: Isavuconazole is an antifungal medicine used to prevent or treat serious fungal infections in people who have received a solid organ transplant (mainly lung, and also kidney or liver) or a hematopoietic stem cell (bone marrow) transplant. Because these patients take medicines that suppress the immune system, they are at high risk of fungal infections. The amount of isavuconazole in the blood can vary widely from person to person, and it is not fully understood what drives these differences or whether higher blood levels are linked to side ...